We are live on
!
Find out more
LS
Leelyn Smith Portfolio holdings
AUM
$822M
Turnover
11.52%
1-Year Est. Return
31.69%
This Fund
S&P 500
This Quarter
Est. Return
+6.37%
1 Year Est. Return
+31.69%
3 Year Est. Return
+77.34%
5 Year Est. Return
+91.98%
10 Year Est. Return
–
AUM
$336M
AUM Growth
+$23.3M
(+7.4%)
Cap. Flow
+$15.2M
Cap. Flow
% of AUM
4.53%
Top 10 Holdings %
Top 10 Hldgs %
40.79%
Holding
397
New
32
Increased
145
Reduced
77
Closed
9
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.55M |
| 2 |
Merck
MRK
|
+$1.96M |
| 3 |
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
|
+$1.95M |
| 4 |
Alibaba
BABA
|
+$1.9M |
| 5 |
ARK Innovation ETF
ARKK
|
+$1.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles Schwab
SCHW
|
+$2.01M |
| 2 |
RTX Corp
RTX
|
+$1.65M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.17M |
| 4 |
First Trust Cloud Computing ETF
SKYY
|
+$863K |
| 5 |
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
|
+$830K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.04% |
| 2 | Technology | 10.61% |
| 3 | Healthcare | 7.68% |
| 4 | Consumer Discretionary | 7.22% |
| 5 | Financials | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Synchrony
SYF
$24.1B
| $17K | 0.01% |
+415
| New | +$16K |
2021 Q1
0 quarters
|
|
252
Target
TGT
$71.2B
| $17K | 0.01% |
86
+1
| +1% | +$187 |
2019 Q4
5 quarters
|
|
253
US Bancorp
USB
$89.4B
| $17K | 0.01% |
300
| – | – |
2019 Q4
5 quarters
|
|
254
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.7B
| $17K | 0.01% |
61
-28
| -31% | -$7.89K |
2019 Q4
5 quarters
|
|
255
iShares Biotechnology ETF
IBB
$10.6B
| $16K | ﹤0.01% |
105
| – | – |
2020 Q2
3 quarters
|
|
256
Vanguard Real Estate ETF
VNQ
$36.7B
| $16K | ﹤0.01% |
176
| – | – |
2019 Q4
5 quarters
|
|
257
Brookfield Infrastructure Partners
BIP
$17.1B
| $15K | ﹤0.01% |
435
-2,880
| -87% | -$100K |
2020 Q1
4 quarters
|
|
258
iShares MSCI EAFE ETF
EFA
$76.9B
| $15K | ﹤0.01% |
+200
| New | +$15.1K |
2021 Q1
0 quarters
|
|
259
Eaton Vance National Municipal Opportunities Trust
EOT
$241M
| $15K | ﹤0.01% |
650
| – | – |
2020 Q2
3 quarters
|
|
260
iShares National Muni Bond ETF
MUB
$49.2B
| $15K | ﹤0.01% |
133
-5
| -4% | -$583 |
2020 Q1
4 quarters
|
|
261
NVIDIA
NVDA
$5.25T
| $15K | ﹤0.01% |
1,120
| – | – |
2020 Q2
3 quarters
|
|
262
Vanguard Morningstar Small-Cap Value ETF
VBR
$36.1B
| $15K | ﹤0.01% |
89
-11
| -11% | -$1.73K |
2019 Q4
5 quarters
|
|
263
Arthur J. Gallagher & Co
AJG
$64.1B
| $14K | ﹤0.01% |
110
| – | – |
2019 Q4
5 quarters
|
|
264
Cracker Barrel
CBRL
$1.51B
| $14K | ﹤0.01% |
82
| – | – |
2019 Q4
5 quarters
|
|
265
Dover
DOV
$26.1B
| $14K | ﹤0.01% |
100
| – | – |
2020 Q4
1 quarter
|
|
266
Eaton
ETN
$156B
| $14K | ﹤0.01% |
100
| – | – |
2019 Q4
5 quarters
|
|
267
Principal Financial Group
PFG
$23.3B
| $14K | ﹤0.01% |
234
| – | – |
2019 Q4
5 quarters
|
|
268
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$2.9B
| $14K | ﹤0.01% |
276
-9
| -3% | -$468 |
2019 Q4
5 quarters
|
|
269
Bausch Health
BHC
$2.36B
| $13K | ﹤0.01% |
400
| – | – |
2020 Q4
1 quarter
|
|
270
Bank of Montreal
BMO
$115B
| $13K | ﹤0.01% |
150
| – | – |
2019 Q4
5 quarters
|
|
271
iShares Core MSCI Europe ETF
IEUR
$9.31B
| $13K | ﹤0.01% |
244
-9
| -4% | -$477 |
2020 Q1
4 quarters
|
|
272
NYLIM Merger Arbitrage ETF
MNA
$258M
| $13K | ﹤0.01% |
404
| – | – |
2019 Q4
5 quarters
|
|
|
RDS.A
273
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $13K | ﹤0.01% |
323
+59
| +22% | +$2.38K |
2019 Q4
5 quarters
|
|
274
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.3B
| $12K | ﹤0.01% |
+150
| New | +$11.6K |
2021 Q1
0 quarters
|
|
275
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.53B
| $12K | ﹤0.01% |
118
| – | – |
2020 Q4
1 quarter
|
|
Similar funds
SCM
SCP
GSWM
HVIA
MGAM
IA
WRPWM
RP
Leelyn Smith's Q1 2021 Portfolio in Review
As of Q1 2021, Leelyn Smith held 397 positions worth $336M, up 7.4% from $313M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Leelyn Smith deployed $15.2M of net new capital in Q1 2021, opening 32 new positions and adding to 145 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 4,717 shares worth $1.01M.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 52% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Charles Schwab, an estimated $2.01M trimmed.
- Leelyn Smith's largest Q1 2021 buy was Vertex Pharmaceuticals: 4,717 shares worth $1.01M.
- Leelyn Smith added most to Invesco QQQ Trust in Q1 2021, an estimated $2.55M increase.
- Leelyn Smith's biggest Q1 2021 reduction was Charles Schwab, cutting an estimated $2.01M.
- Leelyn Smith fully exited Colgate-Palmolive in Q1 2021, selling an estimated $94K.
- Leelyn Smith's ten largest holdings make up 41% of its $336M portfolio in Q1 2021.
- Leelyn Smith opened 32 new positions and closed 9 in Q1 2021.
- Leelyn Smith's portfolio value rose 7.4% quarter-over-quarter to $336M.
Based on Leelyn Smith's 13F filing for Q1 2021, filed 5 May 2021.